There Is a Newer Version
of
this Subchapter
2019 Delaware Code
Title 18 - Insurance Code
Chapter 33. Health Insurance Contracts
Subchapter II Pre-Authorization Transparency
- § 3371 Definitions [Effective until Mar. 18, 2020].
- § 3371 Definitions [For application of this section, see 82 Del. Laws, c. 44, § 3] [Effective Mar. 18, 2020].
- § 3372 Disclosure and review of pre-authorization requirements.
- § 3373 Utilization review entity’s obligations with respect to pre-authorizations in nonemergency circumstances.
- § 3374 Utilization review entity’s obligations with respect to pre-authorization concerning emergency health-care services.
- § 3375 Retrospective denial.
- § 3376 Length of pre-authorization.
- § 3377 Electronic standards for pharmaceutical pre-authorization.
- § 3378 Health-care services deemed preauthorized if a utilization review entity fails to comply with the requirements of this subchapter.
- § 3379 Waiver prohibited.
- § 3380 Exemptions.
- § 3381 Step therapy exception process [For application of this section, see 82 Del. Laws, c. 44, § 3] [Effective Mar. 18, 2020].
Disclaimer: These codes may not be the most recent version. Delaware may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
